Orgenesis Inc. announced the appointment of Scott Carmer as CEO of the company's North American subsidiary. Carmer has more than 25 years of diverse industry experience within both pharmaceutical and biotech companies. Before joining Orgenesis, Carmer led the US Specialty Care Division of AstraZeneca, and had responsibility for the company's portfolio of specialty care biopharmaceutical products.